1. Home
  2. MATV vs IRWD Comparison

MATV vs IRWD Comparison

Compare MATV & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mativ Holdings Inc.

MATV

Mativ Holdings Inc.

HOLD

Current Price

$10.74

Market Cap

701.0M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.55

Market Cap

741.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATV
IRWD
Founded
1995
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
701.0M
741.8M
IPO Year
1996
2009

Fundamental Metrics

Financial Performance
Metric
MATV
IRWD
Price
$10.74
$3.55
Analyst Decision
Strong Buy
Hold
Analyst Count
1
5
Target Price
$10.00
$4.94
AVG Volume (30 Days)
344.4K
2.9M
Earning Date
05-21-2026
05-26-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
1400.00
EPS
N/A
0.15
Revenue
N/A
$298,276,000.00
Revenue This Year
$4.63
$41.42
Revenue Next Year
$3.37
$16.01
P/E Ratio
N/A
$22.77
Revenue Growth
N/A
8.88
52 Week Low
$4.34
$0.55
52 Week High
$15.48
$5.78

Technical Indicators

Market Signals
Indicator
MATV
IRWD
Relative Strength Index (RSI) 32.10 38.49
Support Level $9.95 $3.15
Resistance Level $11.54 $3.73
Average True Range (ATR) 0.75 0.38
MACD -0.39 -0.14
Stochastic Oscillator 4.60 31.95

Price Performance

Historical Comparison
MATV
IRWD

About MATV Mativ Holdings Inc.

Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments namely Filtration & advanced Materials focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging and healthcare solutions.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: